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Abstract 
Rate of acute pancreatitis is up to 40 cases per year per 100,000 adults, while about 10-15% of patients have severe 
forms of this disease, among which the mortality rate reaches 80%. Aim: to experimentally evaluate the 
pharmacological efficacy of the combined use of drugs (immunomodulators, antioxidants and membrane protectors) 
in acute biliary pancreatitis with a high degree of severity. A laboratory rat population was used for the study. 210 
animals were divided into 3 groups. Group 1 did not receive any drugs, group 2 received a combination of ferrovir, 
mexidol and phosphogliv, and group 3 received a combination of polyoxidonium and Essentiale N. Before and after 
the administration of drugs combination, the indicators of the immunological status and parameters of the oxidative 
system were evaluated. Combination of ferrovir, mexidol and phosphogliv with mild pancreatitis corrects 12.0% and 
normalizes 75% of the studied laboratory immune and oxidative indices, respectively. With a moderate degree of 
pancreatitis, these indicators were 19.2% and 45%, and with a severe degree, corresponding to the control values. 
For group 3, drug combination leads to normal laboratory values of immune and oxidative status in mild pancreatitis, 
with moderate severity it normalizes 27% and correlates in 73% of cases, and with severe severe it correlates with all 
studied results. As established experimentally, mild forms of biliary pancreatitis are completely corrected with 
different drug combinations. With moderate and severe severity, there are immunometabolic disorders recorded. 
The combination proposed in this case is neither sufficiently effective nor ineffective. This study has convincingly 
proved the relevance of drug treatment of mild biliary pancreatitis with drug combination on the example of 
laboratory animals. At the same time, drug treatment is ineffective for moderate and severe pancreatitis. The study 
requires the continuation and testing of the resulting drug combination for mild biliary pancreatitis. 
Key words: biliary pancreatitis; ferrovir, mexidol, phosphogliv, polyoxidonium, Essentiale N, combination. 
INTRODUCTION 
Acute pancreatitis (AP) is an enzymatic lesion of the 
pancreas. This process is autocatalytic and often ends 
in autocatalysis and organ necrosis. It determines the 
aseptic inflammation of the demarcation type. The 
cause is necrobiosis and auto-aggression caused by 
enzymes. Subsequently, necrotic changes occur with 
the addition of a secondary purulent infection. This 
can lead to the fact that clinical phenomena can 
manifest themselves in the form of minor pain 
sensations, with variations up to the most severe 
enzymatic shock (Andersen et al., 2008; Agarwal et al., 
2016; Zhuang et al., 2016). The frequency of AP 
development in the world varies from 20 to 120 cases 
per 100,000 population; in Ukraine - 102 per 100,000 
population (Konopljia et al., 2015; Mikaelyan, 2017). 
Factors such as the average age and level of alcohol 
consumption among the population affects the 
disease 
(Bermejo et al., 2008; DiMagno, 2011; Bakker et al., 
2012; Goyal et al., 2016). AP mortality percentage 
remains   very   high   despite   modern   methods   of 
treatment   use:   7–15%   in   total,   30–40%   with 
destructive forms (Brown et al., 2008; Gardner et al., 
2009; van Santvoort et al., 2010; van Brunschot et al., 
2014; Chen et al., 2016). 
Acute pancreatitis is a diagnosis of up to 230,000 
hospitalizations in the United States every year 
(Fagenholz et al., 2007; Crockett et  al., 2018). 
Although moderate acute pancreatitis reaches a 
mortality of only <1%, mortality from severe 
pancreatitis can reach a third of cases (30%) (Freeman 
et al., 2012; Ermolov, 2016). 
Drugs   can   cause   0.1%   -2%   of   cases   of   acute 
pancreatitis (Barkin et al., 2017). Most cases of drug- 
induced pancreatitis are mild or moderate. However, 
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serious and even fatal cases may occur. Treatment of 
acute pancreatitis caused by drugs requires the 
abolition of violating drugs and supportive therapy. If 
it is impossible to identify a drug that is an active 
violating agent, then this can lead to critical delays. 
Prevention of drug-induced pancreatitis requires up- 
to-date knowledge of drugs with strong evidence 
linking their use to the development of pancreatitis. 
At the same time, there is an opposite trend - the need 
to introduce pharmacological methods for the 
correction and treatment of pancreatitis, using the 
results of laboratory experiments. 
The main factor in the emergence and subsequent AP 
development are extrahepatic biliary tract diseases, 
up to 37-45% of all cases of pancreatitis (Krishna et al., 
2015; 2017; Lee et al., 2016; Lorenzo et al., 2017; Huh 
et al., 2018). This is the cause of the development of 
acute biliary pancreatitis (BP). The pathogenesis of 
pancreatitis is manifested as a violation of the 
pancreatic secretory function due to obstruction of 
the major duodenal papilla (MDP) (Mouli et al, 2013; 
McNabb-Baltar et al., 2014; Majumder et al., 2015. 
Chronic biliary pancreatitis (CBP) is therefore a chronic 
inflammatory disease of the pancreas. For BP, a 
combination of the following morphological and 
histological factors is characteristic as follows: 
histological changes of different locations in the part 
of the pancreas associated with excretory-secretory 
function. Later, this part of the pancreas begins to 
degenerate, with the result that the gland tissue is 
replaced by connective tissue cells. At the 
physiological level, disorders are manifested in the 
form of the presence of functional insufficiency of 
various degrees of expression. 
The causes of biliary pancreatitis (BP) in most cases 
(within 35–56%) are pathologies of the biliary tract, 
namely: cholecystitis, disorders at the morphological 
level, resulting in a loss or decrease of duodenum and 
pancreas functions. Thus, BP development is 
determined by a whole complex of disorders, mainly 
at the morphological, histological and physiological 
levels (Phillip et al., 2011; Minkov et al., 2015). 
One of the  insufficiently studied  pharmacotherapy 
methods is the combined use of immunomodulatory, 
membrane-protective and antioxidant 
pharmacotherapy of varying BP severity and etiology. 
Indicators for the use vary and are associated with 
impairments in the immune status and oxidative 
system. They are especially pronounced in severe BP 
forms. Therefore, it is necessary to compare 
pharmacological methods of BP treatment or 
correction depending on its severity - mild, moderate 
and severe. 
Aim: to experimentally evaluate the pharmacological 
efficacy of the combined drugs use 
(immunomodulators, antioxidants and membrane 
protectors) in acute biliary pancreatitis with a high 
degree of severity. 
MATERIALS AND METHODS 
All experiments were performed on a population of 
210 laboratory rats. The average weight of the 
animals, taking into account the average error, was 
219 ± 41 g. The animals were selected according to the 
following principles: a) the same  age; b) 
approximately the corresponding weight category; c) 
the same period of the experiment, 8 am to 12 pm. 
Gender of the surveyed population was not taken into 
account. 
The size of each experimental group is 70 laboratory 
rats. 
To obtain statistically significant data, the group 
consisted of 70 animals. Group 1 did not receive any 
medication, 2 groups of animals were given a 
combination of the following drugs. Medications were 
administered once a day. In total, each of the drugs 
was administered 10 times. The first combination 
consisted of ferrovir, phosphogliv and meskidol. The 
first was administered intramuscularly to each of the 
animals at the rate of 1 kg of body weight at a dose of 
15 mg. Meskidol was administered in 3 times larger 
amount per 1 kg of body weight, but inside the 
abdominal cavity. Finally, phosphogliv was injected 
into the oral cavity, as a solution in 1% starch, at the 
rate of 750 mg per 1 kg of body weight. For the third 
group of animals, a combination of other drugs was 
proposed. This polyoxidonium, emoxipin and 
Essentiale N, 10 times, in different ways. 
Polyoxidonium, like ferrovir, was also administered 
intramuscularly at a dose of 0.025 mg. Injection of 
emoxipin was also carried out intramuscularly as 
follows: 1.5 ml, 1% solution of emoxipin itself, with the 
addition of 20 ml of 1% solution of sodium chloride. 
The resulting solution was administered in an amount 
of 0.5 ml. Essentiale N, as well as mexidol, is entered 
into an abdominal cavity, in a dose of 0.05 ml. 
In order to simulate a situation occurring in the 
pancreas with BP of varying severity, we used the 
following methods.  To simulate all  BP  degrees, 
operations with animals were carried out 5 days 
before killing. The choice of this period is due to the 
fact that the physiological parameters necessary for 
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the study are observed during this specified period of 
time. 
To simulate a mild severity of BP, the animals 
underwent a laparotomy. In the future, using liquid 
nitrogen and a special applicator was applied to one 
of the lobes of the pancreas. After 3 hours, 85% of the 
rats developed edematous syndrome BP. Sequential 
analysis of laboratory results was performed on 
animals with edematous syndrome BP. 
Modeling of moderate and severe types of 
pancreatitis was  carried out by  combining surgical 
intervention (truncating one duct into each of the 
pancreas) and physiological initiation (administration 
of prozerin, once every 60 minutes, dose was 0.25 mg 
per 1 kg of body weight). With this method of 
modeling, destructive pancreatitis development was 
detected morphologically. In order to achieve 
pancreatitis of moderate severity, it is necessary to 
bandage only one pancreatic duct, and to simulate a 
severe form, similar actions were performed with two 
ducts and proserin injection. 
Laboratory parameters of the control group are 
shown on the example of 50 healthy rats. 
Rats were immunized by injecting a sheep red blood 
cells into the abdominal cavity. 110 red blood cells 
were injected per 1 kg of body weight. Indicators of 
the humoral immune response after 5 days were 
recorded on the following grounds: CBC is the number 
of cells localized in the spleen and producing immune 
antibodies. Also taken into account is the difference in 
mass between regional and contralateral lymph nodes 
(Mass difference MD, Number difference ND). 
In the peripheral blood phagocytic index and the 
number of phagocytes was taken into account. 
Oxygen indicators were recorded by standard 
methods (restoration of nitro-synthetic tetrazolium, 
optical density (NBT test)). The levels of AHP (acyl 
hydroperoxide) and MDA (dialdehyde malic (malonic) 
acid) in the blood plasma were taken into account as 
indicators of the intensity of lipid peroxidation. At the 
same time, the total antioxidant activity (TAA) was 
taken into account. All ELISA results were recorded 
using a photometer (Sunrisemicroplate, Tekan 
(Austria)). 
Experimental studies of the reliability of differences 
between the results were determined using statistical 
methods, indicating the data and their errors mean (± 
m) and the probability of a possible error (p), 
calculated using the t-test for independent samples. 
Differences were assessed as significant, prir = 0.05. 
For the calculations, the statistical analysis program 
Microsoft Excel 7.0 is used. In addition, the 
Spearman's rank correlation coefficient was 
determined. 
RESULTS 
In rats with a mild degree of PD, there was a decrease 
in the CBC values in the spleen, whereas in the 
peripheral blood a decrease in the level of MD and ND. 
In the immune system, as it was possible to establish 
the results of NBT test, processes with opposite 
directivity occurred - a significant decrease in the 
activity of phagocytes and an increase in the activity 
of polymorphonuclear-type leukocytes, which is 
dependent on the oxygen level. These data are 
presented in Table 1. 
Other researchers pointed to the fact that metabolic 
disturbances can be only with destructive forms of 
pancreatitis (Krishna et al., 2015; 2017; Lee et al., 
2016,; Lorenzo et al., 2017; Huh et al., 2018). Our 
study allows us to state with confidence that 
metabolic disorders of varying degrees of severity are 
also observed with a mild form of PD. According to our 
data, activation of lipid peroxidation processes was 
detected (in particular, an increase in MDA and AHP), 
as well as a slight increase in SMO in the absence of 
changes in the activity of catalase and TAA (Table 1). 
Table 1. Drug therapy of mild biliary pancreatitis on the example of laboratory rats. 
Indicator Units 1 2 3 4 
Control group Mild BP 
No drugs Ferrovir + mex 
+ 
phosphogliv 
Polyoxidonium 
emoxipin + 
Essentiale N 
AHP units 0.40± 0.04 0.47±0.04 0.23±0.05 0.37±0.05 
MDA umol/l 1.8±0.8 4.9±0.3 1.75±0.03 1.68±0.02 
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SМNO umol/l 1.77±0.8 2.81±0.05 1.93±0.2 1.71±0.09 
ОАА % 48.0±0.6 48.2±0.6 42.1±0.3 47.8±0.6 
Drugs selected in the experiment, are actively used as 
an immunomodulator, membrane protector and 
antioxidant, in particular for violations of the 
hepatopancreatobiliary system. 
Our data showed that in a group of rats with a mild 
PD, a combination of ferrovir, mexidol and 
phosphogliv normalized the development of the 
humoral form of immunity, and also corrected the 
formation of the cellular (MD, ND) form. Due to the 
use of this combination, the functional activity of 
peripheral blood neutrophils and oxidative indices 
(Table 1) were completely normalized in rats. MDA 
indices in group 2 significantly decreased 2.5 times as 
compared with control, AHP indices - by half (Table 1). 
On the other hand, the introduction of the second 
group of drugs, namely polyoxidonium, emoxipine 
and Essentiale N, normalized the parameters of 
humoral and cellular immune response, the activity of 
granulocytes in the blood, indicators of the oxidative 
system. 
Simulation of a more pronounced compared with a 
mild and moderate PD, showed a significantly more 
pronounced degree of reduction in CBC (localization - 
the spleen). In addition, indicators of MD and ND, as 
well as all indicators of phagocytosis, have changed in 
the direction of decline. For MDA, approximately the 
same decline was recorded as with the introduction of 
the first combination of drugs, for AHP - a higher level 
(Table 1). This means that the processes associated 
with AHD and MDA with the second combination of 
drugs are more pronounced. 
When modeling PD of moderate severity, the group of 
laboratory rats showed a more pronounced reduction 
in the number of antibody-forming cells (AFC) in the 
spleen compared to the mild form, as well as 
indicators of MD and ND of regional and contralateral 
lymph nodes, and indicators of phagocytosis 
(phagocytic coefficient PC, phagocytic index PI, 
phagocytes activity index PAI), increase of parameters 
of oxygen-dependent activity of peripheral blood 
neutrophils. Revealed a more pronounced activation 
of the processes of lipid peroxidation (increased AHP, 
MDA), a decrease in the activity of catalase, OAA. 
Increasing the level of substances associated with NO 
also suggests a more  significant  activation of  lipid 
peroxidation processes (Table 2). 
Table 2. Drug therapy of moderate biliary pancreatitis on the example of laboratory rats. 
Indicator Units 1 2 3 4 
Control group Mild BP 
No drugs Ferrovir + Mex 
+ 
phosphogliv 
Polyoxidonium 
emoxipin + 
Essentiale N 
AHP units 0.40± 0.04 7.4±0.08 5.5±0.05 1.37±0.05 
MDA umol/l 1.8±0.8 20.9±0.5 16.7±1.0 11. 8±1.9 
SМNO umol/l 1.77±0.8 2.6±0.09 3.1±0.20 3.7±0.07 
TAA % 48.0±0.6 25.2±1.6 27.1±0.9 33.8±1.6 
AFC thousand/splee 26.9±2.3 7.8±1.5 26.8±1.6 26.3±1.4 
MD мг 2.45±0.03 0.26±0.02 0.55±0.05 1.6±0.06 
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ND 106 of lymphocy 1.82±0.04 0.12±0.02 0.14±0.02 0.68±0.07 
The first combination of drugs resulted in normal AFC 
level in rats’ spleen, and also corrected the processes 
of phagocytosis (phagocytic coefficient, phagocytic 
index, phagocytes activity index), the content of lipid 
peroxidation products, catalase activity, TAA, 
increased levels of СNO in plasma. No effect on 
cellular immunity, oxygen-dependent activity of 
peripheral blood neutrophils (Table 2) was noted. 
The second combination of drugs normalized the 
following parameters: the number of immune AFC in 
the spleen, phagocytosis, corrected, but not to normal 
values, indicators of MD and ND and TAA. The 
coefficients of the AAFC and SМNO compared with 
the control decreased by 0.7 and increased 2 times, 
respectively (Table 2). 
In the third experiment, associated with severe BP, 
the following differences were reliably established. 
When combining drugs group 1, differences from 
control were at the level of 1st order, between rats 
group 1 and group, 2 differences were not significant, 
while the combination of drugs groups 2 in rats group 
reduced AHP level by 4 times. Yet this AHP level was 
10 times higher than normal. The same pattern is fixed 
for MDA (Table 3). Opposite processes (decrease) 
were recorded for SNNO (2 times decrease), TАА and 
AFC (4-5 times decrease in comparison with the 
control), as well as MD, ND (decrease by more than 1 
order). 
Table 3. Drug therapy of severe biliary pancreatitis on the example of laboratory rats. 
Indicator Units 1 2 3 4 
Control group Severe BP 
No drugs Ferrovir + Mex 
+ 
phosphogliv 
Polyoxidonium 
emoxipin + 
Essentiale N 
AHP units 0.40± 0.04 17.9±0.9 16.8±0.5 4.7±0.05 
MDA umol/l 1.8±0.8 30.9±3.5 31.7±2.7 18. 2±2.1 
SМNO umol/l 1.77±0.8 0.6±0.4 0.8±0.05 0.85±0.07 
TAA % 48.0±0.6 10.9±1.5 12.1±0.9 17.8±0.9 
AFC thousand/splee 26.9±2.3 5.8±1.4 5.6±1.1 16.3±1.4 
MD мг 2.45±0.03 0.15±0.02 0.11±0.01 0.9±0.02 
ND 106 of lymphocy 1.82±0.04 0.07±0.02 0.04±0.01 0.12±0.03 
Thus, it can be argued that in severe BP, the 
administration of both groups of drugs 2 and 3 to a 
group  of  laboratory  animals  did  not  change  the 
parameters   of   physiological   stress,   but   on   the 
contrary, either reduced them or increased them. 
None    of    the    studied    immune    and    oxidative 
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parameters could not be normalized with the 
introduction of the second group of drugs. The use of 
this combination in severe CP corrected, but not to 
normal indicators of AFC, MD, ND, PC, PAI, the level of 
MDA and AHP, TAA and SМNO level. 
DISCUSSION 
Negative correlations were found between the 
indicators of adaptive forms of the immune response 
and the processes of phagocytosis. On the other hand, 
positive, reliable correlations were found between the 
oxygen-dependent activity of peripheral blood 
neutrophils and oxidative indicators. In total, between 
48 indicators of immunity and oxidative status 
revealed 48 significant correlations. 
In moderately severe PD, the total correlation number 
was 43. Indicators of humoral, cellular forms of the 
immune response and lipid peroxidation products 
(MDA and AHP) showed negative correlation links. 
Catalase and TAA activity is positive. The metabolic 
activity of peripheral blood neutrophils showed 
positive correlations with LPO products and negative 
with catalase and TAA. The titer of stable NO 
metabolites did not correlate with the parameters of 
innate and adaptive immunity. 
When modeling severe PD, all indicators of the 
immune and oxidative systems correlated. 50 
significant correlations were found. At the same time, 
positive correlations were found between the 
humoral, cellular forms of the immune response, 
phagocytosis processes and catalase activity, TAA, as 
well as the level of SМNO. Negative correlations are 
manifested between antioxidant indices and 
metabolic activity of peripheral blood neutrophils. 
Thus, it can be concluded that in case of mild PD, the 
changes are minimal and are completely corrected by 
both combinations of drugs, then the mean and 
severe forms of PD are more pronounced 
immunometabolic disorders. These physiological 
disturbances are not effectively corrected by the 
proposed combinations. The obtained data on 
moderate and severe degrees and pharmacological 
correction of the proposed drug combinations are 
consistent with the results obtained by other 
researchers (Brown et al., 2008; Gardner et al., 2009; 
Peery et al., 2012; Chen et al., 2016; Polyansky, 2017). 
The problem of treating biliary pancreatitis is far from 
being resolved. The choice of surgical tactics, 
pharmacological therapy or accompaniment, 
corrections remain controversial (Brown et al., 2008; 
Samokhvalov et al., 2015; Chen et al., 2016; Ramos et 
al., 2016; Schmidt et al., 2017). 
BP is known to be one of the most difficult diagnoses, 
often ending with complications or death (Setiawan et 
al., 2017; Sellers et al., 2018). There are several ways 
of therapy, but all of them are united by the time 
factor - it is necessary to start therapy at an early 
stage, immediately after diagnosis set (Tenner et al., 
2013; WorkingGroup, 2013). In the case of the actual 
medical examination without treatment, various 
pathologies of the liver and pancreas develop. 
Pathology manifests itself in the form of hypertension 
in the ducts, as a result of this - noninfectious jaundice 
develops, various kinds of inflammatory processes, 
resulting in necrotic changes in the pancreas 
(Fagenholz et al., 2007; Wu et al., 2008; Crockett et al., 
2018; Vege et al., 2018). At the cellular level, this is 
manifested as the cessation of hepatocytes 
functioning, at the system level - in the cessation of 
the reticuloendothelial system functioning. The 
physiological level also undergoes significant and fatal 
changes - endothelium toxicosis occurs, stress from an 
increased content of free radicals, and other 
processes. At the macro level, stones form in the 
pancreas, and as a result, necrosis develops. In this 
case, even an urgent surgical intervention will not 
correct the situation. 
The urgency of the question remains quite acute 
today, as it is necessary to develop new methods for 
detecting and treating PD, their complex application 
and detailed analysis of preliminary results obtained 
from laboratory experiments (van Santvoort et al., 
2010; van Brunschot et al, 2014). 
Pharmacotherapy is one of the ways to treat mild PD, 
to stabilize the more severe degrees of this disease. 
The primary issue remains the development and 
introduction of new methods for monitoring and 
diagnosing people with BP. 
The combination of ferrovir, mexidol, and phosphogliv 
in mild pancreatitis is 12.0% and normalizes 75% of 
the studied laboratory immune and oxidative 
parameters, respectively. With an average degree of 
pancreatitis, these indicators were 19.2%, 45%, and 
with a severe degree, it corresponds to the values of 
the control group. 
CONCLUSIONS 
This study has convincingly proved the relevance of 
drug treatment of mild forms of biliary pancreatitis 
with a combination of drugs on the example of 
laboratory animals. At the same time, drug treatment 
is ineffective for moderate to severe pancreatitis. The 
study requires the continuation and testing of the 
resulting combination of drugs in patients with mild 
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biliary pancreatitis. 
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